KEAP1 c.997G>T ;(p.G333C)

Variant ID: 19-10602581-C-A

NM_203500.1(KEAP1):c.997G>T;(p.G333C)

This variant was identified in 70 publications

View GRCh38 version.




Publications:


Regulation of Cell Proliferation and Nrf2-Mediated Antioxidant Defense: Conservation of Keap1 Cysteines and Nrf2 Binding Site in the Context of the Evolution of KLHL Family.

Life (Basel, Switzerland)
Shilovsky, Gregory A GA; Dibrova, Daria V DV
Publication Date: 2023-04-19

Variant appearance in text: KLHL19: G333C
PubMed Link: 37109574
Variant Present in the following documents:
  • Main text
  • life-13-01045.pdf
View BVdb publication page



Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery
Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI
Publication Date: 2023-03-02

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 36862804
Variant Present in the following documents:
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6
View BVdb publication page



An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology
Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y
Publication Date: 2022

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 36505399
Variant Present in the following documents:
  • Table_2.xlsx, sheet 2
View BVdb publication page



Design and characterization of a heterobifunctional degrader of KEAP1.

Redox Biology
Chen, Hao H; Nguyen, Nghi H NH; Magtoto, Charlene M CM; Cobbold, Simon A SA; Bidgood, Grace M GM; Meza Guzman, Lizeth G LG; Richardson, Lachlan W LW; Corbin, Jason J; Au, Amanda E AE; Lechtenberg, Bernhard C BC; Feltham, Rebecca R; Sutherland, Kate D KD; Grohmann, Christoph C; Nicholson, Sandra E SE; Sleebs, Brad E BE
Publication Date: 2022-11-26

Variant appearance in text: KEAP1: G333C
PubMed Link: 36473314
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: KEAP1: G333C
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



The mutational landscape of cancer's vulnerability to ionizing radiation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
Publication Date: 2022-10-12

Variant appearance in text: KEAP1: G333C
PubMed Link: 36222846
Variant Present in the following documents:
  • Main text
  • ccr-22-1914_supplementary_data_2_suppds2.xlsx, sheet 1
  • ccr-22-1914_supplementary_data_3_suppds3.xlsx, sheet 1
  • 5343.pdf
View BVdb publication page



Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer.

Nature Communications
Bartolacci, Caterina C; Andreani, Cristina C; Vale, Gonçalo G; Berto, Stefano S; Melegari, Margherita M; Crouch, Anna Colleen AC; Baluya, Dodge L DL; Kemble, George G; Hodges, Kurt K; Starrett, Jacqueline J; Politi, Katerina K; Starnes, Sandra L SL; Lorenzini, Daniele D; Raso, Maria Gabriela MG; Solis Soto, Luisa M LM; Behrens, Carmen C; Kadara, Humam H; Gao, Boning B; Wistuba, Ignacio I II; Minna, John D JD; McDonald, Jeffrey G JG; Scaglioni, Pier Paolo PP
Publication Date: 2022-07-26

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 35882862
Variant Present in the following documents:
  • 41467_2022_31963_MOESM13_ESM.xlsx, sheet 1
View BVdb publication page



Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.

Cancer Communications (London, England)
Han, Jang Hee JH; Kim, Yong Keon YK; Kim, Hakhyun H; Lee, Jooyoung J; Oh, Myung Joon MJ; Kim, Sang Bum SB; Kim, Minjee M; Kim, Kook Hwan KH; Yoon, Hyun Ju HJ; Lee, Myung-Shik MS; Minna, John D JD; White, Michael A MA; Kim, Hyun Seok HS
Publication Date: 2022-08

Variant appearance in text: KEAP1: G333C
PubMed Link: 35838183
Variant Present in the following documents:
  • Main text
  • CAC2-42-716.pdf
View BVdb publication page



Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation.

Cancer Drug Resistance (Alhambra, Calif.)
Paramasivan, Poornima P; Kumar, Jothi Dinesh JD; Baskaran, Rathinasamy R; Weng, Ching Feng CF; Padma, Viswanadha Vijaya VV
Publication Date: 2020

Variant appearance in text: KEAP1: G333C
PubMed Link: 35582448
Variant Present in the following documents:
  • cdr-3-647.pdf
View BVdb publication page



miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways.

Molecular Therapy. Nucleic Acids
Bi, Guoshu G; Liang, Jiaqi J; Zhao, Mengnan M; Zhang, Huan H; Jin, Xing X; Lu, Tao T; Zheng, Yuansheng Y; Bian, Yunyi Y; Chen, Zhencong Z; Huang, Yiwei Y; Besskaya, Valeria V; Zhan, Cheng C; Wang, Qun Q; Tan, Lijie L
Publication Date: 2022-06-14

Variant appearance in text: KEAP1: G333C
PubMed Link: 35505963
Variant Present in the following documents:
  • Main text
  • main.pdf
  • mmc2.pdf
View BVdb publication page



A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.

Nature Communications
Koppula, Pranavi P; Lei, Guang G; Zhang, Yilei Y; Yan, Yuelong Y; Mao, Chao C; Kondiparthi, Lavanya L; Shi, Jiejun J; Liu, Xiaoguang X; Horbath, Amber A; Das, Molina M; Li, Wei W; Poyurovsky, Masha V MV; Olszewski, Kellen K; Gan, Boyi B
Publication Date: 2022-04-22

Variant appearance in text: KEAP1: G333C
PubMed Link: 35459868
Variant Present in the following documents:
  • Main text
  • 41467_2022_Article_29905.pdf
  • 41467_2022_29905_MOESM1_ESM.pdf
  • 41467_2022_29905_MOESM2_ESM.pdf
View BVdb publication page



Cell Painting predicts impact of lung cancer variants.

Molecular Biology Of The Cell
Caicedo, Juan C JC; Arevalo, John J; Piccioni, Federica F; Bray, Mark-Anthony MA; Hartland, Cathy L CL; Wu, Xiaoyun X; Brooks, Angela N AN; Berger, Alice H AH; Boehm, Jesse S JS; Carpenter, Anne E AE; Singh, Shantanu S
Publication Date: 2022-05-15

Variant appearance in text: KEAP1: G333C
PubMed Link: 35353015
Variant Present in the following documents:
  • Main text
  • mbc-33-ar49.pdf
View BVdb publication page



Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.

Bmc Cancer
Zhang, Ying Y; Wang, Weiya W; Hu, Qianrong Q; Liang, Zuoyu Z; Zhou, Ping P; Tang, Yuan Y; Jiang, Lili L
Publication Date: 2022-03-24

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 35331190
Variant Present in the following documents:
  • 12885_2022_9391_MOESM1_ESM.pdf
View BVdb publication page



Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021

Variant appearance in text: KEAP1: 997G>T; Gly333Cys
PubMed Link: 34887858
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
  • Table_4.xlsx, sheet 1
View BVdb publication page



Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure.

Frontiers In Oncology
Dai, Shun-Dong SD; Wang, Shuang S; Qin, Ya-Nan YN; Zhu, Jin-Chao JC
Publication Date: 2021

Variant appearance in text: KEAP1: G333C
PubMed Link: 34858801
Variant Present in the following documents:
  • Table_1.xls, sheet 1
View BVdb publication page



Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.

Science Advances
Ding, Hongyu H; Chen, Zihong Z; Wu, Katherine K; Huang, Shih Ming SM; Wu, Warren L WL; LeBoeuf, Sarah E SE; Pillai, Ray G RG; Rabinowitz, Joshua D JD; Papagiannakopoulos, Thales T
Publication Date: 2021-11-19

Variant appearance in text: KEAP1: G333C
PubMed Link: 34788087
Variant Present in the following documents:
  • Main text
  • sciadv.abk1023.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: KEAP1: G333C
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Triptolide Downregulates the Expression of NRF2 Target Genes by Increasing Cytoplasmic Localization of NRF2 in A549 Cells.

Frontiers In Pharmacology
Nam, Le Ba LB; Choi, Won Jun WJ; Keum, Young-Sam YS
Publication Date: 2021

Variant appearance in text: KEAP1: G333C
PubMed Link: 34566633
Variant Present in the following documents:
  • Main text
  • fphar-12-680167.pdf
View BVdb publication page



KEAP1 Cancer Mutants: A Large-Scale Molecular Dynamics Study of Protein Stability.

International Journal Of Molecular Sciences
Wilson, Carter J CJ; Chang, Megan M; Karttunen, Mikko M; Choy, Wing-Yiu WY
Publication Date: 2021-05-20

Variant appearance in text: KEAP1: G333C
PubMed Link: 34065616
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of a Stable, Non-Canonically Regulated Nrf2 Form in Lung Cancer Cells.

Antioxidants (Basel, Switzerland)
Mikac, Sara S; Rychłowski, Michał M; Dziadosz, Alicja A; Szabelska-Beresewicz, Alicja A; Fahraeus, Robin R; Hupp, Theodore T; Sznarkowska, Alicja A
Publication Date: 2021-05-15

Variant appearance in text: KEAP1: G333C
PubMed Link: 34063559
Variant Present in the following documents:
  • Main text
  • antioxidants-10-00786.pdf
View BVdb publication page



KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer.

Cancers
Hill, Kristen S KS; McDowell, Anthony A; McCorkle, J Robert JR; Schuler, Erin E; Ellingson, Sally R SR; Plattner, Rina R; Kolesar, Jill M JM
Publication Date: 2021-04-14

Variant appearance in text: KEAP1: G333C
PubMed Link: 33920029
Variant Present in the following documents:
  • Main text
View BVdb publication page



Spatially interacting phosphorylation sites and mutations in cancer.

Nature Communications
Huang, Kuan-Lin KL; Scott, Adam D AD; Zhou, Daniel Cui DC; Wang, Liang-Bo LB; Weerasinghe, Amila A; Elmas, Abdulkadir A; Liu, Ruiyang R; Wu, Yige Y; Wendl, Michael C MC; Wyczalkowski, Matthew A MA; Baral, Jessika J; Sengupta, Sohini S; Lai, Chin-Wen CW; Ruggles, Kelly K; Payne, Samuel H SH; Raphael, Benjamin B; Fenyö, David D; Chen, Ken K; Mills, Gordon G; Ding, Li L
Publication Date: 2021-04-19

Variant appearance in text: KEAP1: G333C
PubMed Link: 33875650
Variant Present in the following documents:
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 1
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers.

Nature Communications
Okazaki, Keito K; Anzawa, Hayato H; Liu, Zun Z; Ota, Nao N; Kitamura, Hiroshi H; Onodera, Yoshiaki Y; Alam, Md Morshedul MM; Matsumaru, Daisuke D; Suzuki, Takuma T; Katsuoka, Fumiki F; Tadaka, Shu S; Motoike, Ikuko I; Watanabe, Mika M; Hayasaka, Kazuki K; Sakurada, Akira A; Okada, Yoshinori Y; Yamamoto, Masayuki M; Suzuki, Takashi T; Kinoshita, Kengo K; Sekine, Hiroki H; Motohashi, Hozumi H
Publication Date: 2020-11-20

Variant appearance in text: KEAP1: G333C
PubMed Link: 33219226
Variant Present in the following documents:
  • 41467_2020_19593_MOESM4_ESM.xlsx, sheet 8
View BVdb publication page



KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
Shao, Na N; Huang, Hong H; Idris, Muhammad M; Peng, Xu X; Xu, Feng F; Dong, Shiwu S; Liu, Chungang C
Publication Date: 2020-11

Variant appearance in text: KEAP1: G333C
PubMed Link: 33173725
Variant Present in the following documents:
  • Main text
  • ADVS-7-2001018-s001.pdf
  • ADVS-7-2001018.pdf
View BVdb publication page



Deep phylogeny of cancer drivers and compensatory mutations.

Communications Biology
Rochman, Nash D ND; Wolf, Yuri I YI; Koonin, Eugene V EV
Publication Date: 2020-10-02

Variant appearance in text: KEAP1: G333C
PubMed Link: 33009502
Variant Present in the following documents:
  • Main text
  • 42003_2020_1276_MOESM14_ESM.xlsx, sheet 1
  • 42003_2020_Article_1276.pdf
View BVdb publication page



Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2.

Molecular And Cellular Biology
Baird, Liam L; Suzuki, Takafumi T; Takahashi, Yushi Y; Hishinuma, Eiji E; Saigusa, Daisuke D; Yamamoto, Masayuki M
Publication Date: 2020-10-26

Variant appearance in text: KEAP1: G333C
PubMed Link: 32868290
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of relevant genetic alterations in cancer using topological data analysis.

Nature Communications
Rabadán, Raúl R; Mohamedi, Yamina Y; Rubin, Udi U; Chu, Tim T; Alghalith, Adam N AN; Elliott, Oliver O; Arnés, Luis L; Cal, Santiago S; Obaya, Álvaro J ÁJ; Levine, Arnold J AJ; Cámara, Pablo G PG
Publication Date: 2020-07-30

Variant appearance in text: KEAP1: G333C
PubMed Link: 32732999
Variant Present in the following documents:
  • 41467_2020_17659_MOESM3_ESM.xls, sheet 1
View BVdb publication page



Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation.

Cell Communication And Signaling : Ccs
Gong, Meiling M; Li, Yan Y; Ye, Xiaoping X; Zhang, Linlin L; Wang, Zhifang Z; Xu, Xiaowen X; Shen, Yejing Y; Zheng, Cuixia C
Publication Date: 2020-06-23

Variant appearance in text: KEAP1: G333C
PubMed Link: 32576270
Variant Present in the following documents:
  • Main text
  • 12964_2020_Article_568.pdf
View BVdb publication page



Integrated data analysis reveals significant associations of KEAP1 mutations with DNA methylation alterations in lung adenocarcinomas.

Aging
Elshaer, Mohamed M; ElManawy, Ahmed Islam AI; Hammad, Ahmed A; Namani, Akhileshwar A; Wang, Xiu Jun XJ; Tang, Xiuwen X
Publication Date: 2020-04-23

Variant appearance in text: KEAP1: G333C
PubMed Link: 32327612
Variant Present in the following documents:
  • aging-12-103068-s001..xlsx, sheet 1
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: KEAP1: G333C
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone.

Redox Biology
Torrente, Laura L; Prieto-Farigua, Nicolas N; Falzone, Aimee A; Elkins, Cody M CM; Boothman, David A DA; Haura, Eric B EB; DeNicola, Gina M GM
Publication Date: 2020-02

Variant appearance in text: KEAP1: G333C
PubMed Link: 32007910
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.

Communications Biology
Dong, Xiaobao X; Huang, Dandan D; Yi, Xianfu X; Zhang, Shijie S; Wang, Zhao Z; Yan, Bin B; Chung Sham, Pak P; Chen, Kexin K; Jun Li, Mulin M
Publication Date: 2020-01-07

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 31925297
Variant Present in the following documents:
  • 42003_2019_736_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Impacts of NRF2 activation in non-small-cell lung cancer cell lines on extracellular metabolites.

Cancer Science
Saigusa, Daisuke D; Motoike, Ikuko N IN; Saito, Sakae S; Zorzi, Michael M; Aoki, Yuichi Y; Kitamura, Hiroshi H; Suzuki, Mikiko M; Katsuoka, Fumiki F; Ishii, Hirofumi H; Kinoshita, Kengo K; Motohashi, Hozumi H; Yamamoto, Masayuki M
Publication Date: 2020-02

Variant appearance in text: KEAP1: 997G>T
PubMed Link: 31828882
Variant Present in the following documents:
  • CAS-111-667-s002.xlsx, sheet 2
View BVdb publication page



The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells.

Scientific Reports
Silva, Matheus Molina MM; Rocha, Clarissa Ribeiro Reily CRR; Kinker, Gabriela Sarti GS; Pelegrini, Alessandra Luiza AL; Menck, Carlos Frederico Martins CFM
Publication Date: 2019-11-27

Variant appearance in text: KEAP1: G333C
PubMed Link: 31776385
Variant Present in the following documents:
  • Main text
View BVdb publication page



Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop.

Nature Communications
Wang, Jiancheng J; Lu, Qiying Q; Cai, Jianye J; Wang, Yi Y; Lai, Xiaofan X; Qiu, Yuan Y; Huang, Yinong Y; Ke, Qiong Q; Zhang, Yanan Y; Guan, Yuanjun Y; Wu, Haoxiang H; Wang, Yuanyuan Y; Liu, Xin X; Shi, Yue Y; Zhang, Kang K; Wang, Maosheng M; Peng Xiang, Andy A
Publication Date: 2019-11-06

Variant appearance in text: KEAP1: G333C
PubMed Link: 31695040
Variant Present in the following documents:
  • Main text
  • 41467_2019_Article_12925.pdf
  • 41467_2019_12925_MOESM2_ESM.pdf
View BVdb publication page



Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review.

Cell Communication And Signaling : Ccs
Qin, Jiang-Jiang JJ; Cheng, Xiang-Dong XD; Zhang, Jia J; Zhang, Wei-Dong WD
Publication Date: 2019-09-11

Variant appearance in text: KEAP1: G333C
PubMed Link: 31511020
Variant Present in the following documents:
  • Main text
View BVdb publication page



Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing.

International Journal Of Molecular Sciences
Fabrizio, Federico Pio FP; Sparaneo, Angelo A; Centra, Flavia F; Trombetta, Domenico D; Storlazzi, Clelia Tiziana CT; Graziano, Paolo P; Maiello, Evaristo E; Fazio, Vito Michele VM; Muscarella, Lucia Anna LA
Publication Date: 2019-05-31

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 31159323
Variant Present in the following documents:
  • Main text
  • ijms-20-02697.pdf
View BVdb publication page



Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients.

Bmc Cancer
Koyama, Takahiko T; Rhrissorrakrai, Kahn K; Parida, Laxmi L
Publication Date: 2019-02-01

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 30709382
Variant Present in the following documents:
  • 12885_2019_5313_MOESM2_ESM.xlsx, sheet 1
  • 12885_2019_5313_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



A catalogue of somatic NRF2 gain-of-function mutations in cancer.

Scientific Reports
Kerins, Michael John MJ; Ooi, Aikseng A
Publication Date: 2018-08-27

Variant appearance in text: KEAP1: G333C
PubMed Link: 30150714
Variant Present in the following documents:
  • Main text
  • 41598_2018_Article_31281.pdf
View BVdb publication page



Genetic and transcriptional evolution alters cancer cell line drug response.

Nature
Ben-David, Uri U; Siranosian, Benjamin B; Ha, Gavin G; Tang, Helen H; Oren, Yaara Y; Hinohara, Kunihiko K; Strathdee, Craig A CA; Dempster, Joshua J; Lyons, Nicholas J NJ; Burns, Robert R; Nag, Anwesha A; Kugener, Guillaume G; Cimini, Beth B; Tsvetkov, Peter P; Maruvka, Yosef E YE; O'Rourke, Ryan R; Garrity, Anthony A; Tubelli, Andrew A AA; Bandopadhayay, Pratiti P; Tsherniak, Aviad A; Vazquez, Francisca F; Wong, Bang B; Birger, Chet C; Ghandi, Mahmoud M; Thorner, Aaron R AR; Bittker, Joshua A JA; Meyerson, Matthew M; Getz, Gad G; Beroukhim, Rameen R; Golub, Todd R TR
Publication Date: 2018-08

Variant appearance in text: KEAP1: 997G>T; G333C
PubMed Link: 30089904
Variant Present in the following documents:
  • NIHMS977514-supplement-Sup_Table_17.xlsx, sheet 1
View BVdb publication page



MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Bmc Genomics
Cai, Weijing W; Zhou, Dapeng D; Wu, Weibo W; Tan, Wen Ling WL; Wang, Jiaqian J; Zhou, Caicun C; Lou, Yanyan Y
Publication Date: 2018-08-03

Variant appearance in text: KEAP1: G333C
PubMed Link: 30075702
Variant Present in the following documents:
  • 12864_2018_4958_MOESM4_ESM.xlsx, sheet 1
  • 12864_2018_4958_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



"Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.

Cell Cycle (Georgetown, Tex.)
Best, Sarah A SA; Sutherland, Kate D KD
Publication Date: 2018

Variant appearance in text: KEAP1: G333C
PubMed Link: 30009666
Variant Present in the following documents:
  • Main text
View BVdb publication page